Analyst Consensus ?
ConsensusBuy51 ratings
Bullish3058.8%
Neutral2141.2%
Bearish00.0%
FN2 Earnings Intelligence
Medtronic plc analyst ratings
Medtronic plc (MDT) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$86.88Current
$77Low
$105.12Average
$155High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Jul 10, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 6, 2026 |
| Needham | Buy | Buy | Maintain | Jun 17, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jun 5, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jun 5, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jun 4, 2026 |
| UBS | Neutral | Neutral | Maintain | Jun 4, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jun 4, 2026 |
| Leerink Partners | Outperform | Outperform | Maintain | Jun 4, 2026 |
| BTIG | Buy | Neutral | Upgrade | Jun 4, 2026 |
| Baird | Neutral | Neutral | Maintain | Jun 4, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jun 3, 2026 |
| Truist Securities | Hold | Hold | Maintain | Apr 15, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 7, 2026 |
| Argus Research | Buy | Buy | Maintain | Apr 6, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Apr 1, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 1, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Feb 18, 2026 |
| William Blair | Outperform | Market Perform | Upgrade | Jan 6, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Nov 19, 2025 |
| Stifel | Hold | Hold | Maintain | Oct 9, 2025 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Jun 30, 2025 |
| Oppenheimer | Perform | Perform | Maintain | Aug 21, 2024 |
| Jefferies | Hold | Hold | Maintain | Oct 12, 2022 |
| Raymond James | Market Perform | Outperform | Downgrade | Aug 24, 2022 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Jun 1, 2022 |
| Deutsche Bank | Buy | Buy | Maintain | May 27, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | May 27, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 23, 2022 |
| SVB Leerink | Market Perform | Market Perform | Maintain | Jan 21, 2022 |
| CFRA | Strong Buy | Buy | Upgrade | May 21, 2020 |
| DZ Bank | Hold | Buy | Downgrade | May 14, 2020 |
| BTIG Research | Buy | Buy | Maintain | Feb 19, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jan 8, 2020 |
| Guggenheim Securities | Buy | Neutral | Upgrade | Jan 2, 2020 |
| Guggenheim | Buy | Neutral | Upgrade | Jan 2, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Aug 21, 2019 |
| BMO Capital | Outperform | Outperform | Maintain | Aug 21, 2019 |
| Argus | Buy | Buy | Maintain | Oct 8, 2018 |
| Bank of America | Buy | Buy | Maintain | Aug 22, 2018 |
| B of A Securities | Buy | Buy | Maintain | Aug 22, 2018 |
| Leerink Swann | Market Perform | Market Perform | Maintain | Oct 9, 2017 |
| Nomura | Buy | Buy | Maintain | Mar 17, 2016 |
| Wedbush | Neutral | Neutral | Maintain | Nov 19, 2014 |
| Sterne Agee | Neutral | Neutral | Maintain | Sep 11, 2014 |
| PiperJaffray | Overweight | Overweight | Maintain | Nov 20, 2013 |
| Wunderlich Securities | Hold | Hold | Maintain | May 22, 2013 |
| Wunderlich | Hold | Hold | Maintain | May 22, 2013 |
| Lazard | Neutral | Buy | Downgrade | Feb 14, 2013 |
| Bank oferica | Buy | Buy | Maintain | Apr 5, 2012 |
| Brean Capital | Buy | Buy | Maintain | Feb 22, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $86.88. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Priya Sachdeva | $100 | $84.22 | +15.1% | Jul 28, 2026 |
| BTIG | Ryan Zimmerman | $91 | $83.87 | +4.7% | Jul 13, 2026 |
| Evercore ISI | Analyst unavailable | $105 | $81.61 | +20.9% | Jul 6, 2026 |
| Piper Sandler | Matt O'Brien | $85 | $81.14 | -2.2% | Jun 16, 2026 |
| Goldman Sachs | David Roman | $83 | $82.28 | -4.5% | Jun 5, 2026 |
| Truist Financial | Analyst unavailable | $86 | $81.64 | -1.0% | Jun 4, 2026 |
| Bernstein | Lee Hambright | $97 | $82.54 | +11.6% | Jun 4, 2026 |
| Robert W. Baird | David Rescott | $85 | $77.95 | -2.2% | Jun 4, 2026 |
| UBS | Priya Sachdeva | $85 | $77.95 | -2.2% | Jun 4, 2026 |
| Jefferies | Matthew Taylor | $88 | $77.95 | +1.3% | Jun 4, 2026 |
| BTIG | Analyst unavailable | $90 | $77.95 | +3.6% | Jun 3, 2026 |
| Stifel Nicolaus | Rick Wise | $80 | $77.95 | -7.9% | Jun 3, 2026 |
| Needham | Mike Matson | $101 | $78.03 | +16.3% | Jun 3, 2026 |
| Mizuho Securities | Anthony Petrone | $100 | $73.75 | +15.1% | Jun 3, 2026 |
| Goldman Sachs | Analyst unavailable | $84 | $78.15 | -3.3% | May 21, 2026 |
| Jefferies | Matthew Taylor | $95 | $83.79 | +9.3% | Apr 23, 2026 |
| Truist Financial | Richard Newitter | $95 | $86.88 | +9.3% | Apr 15, 2026 |
| Mizuho Securities | Analyst unavailable | $120 | $86.75 | +38.1% | Apr 13, 2026 |
| Evercore ISI | Vijay Kumar | $106 | $87.91 | +22.0% | Apr 9, 2026 |
| Leerink Partners | Mike Kratky | $119 | $90.3 | +37.0% | Mar 10, 2026 |
| Needham | Michael Matson | $120 | $90.21 | +38.1% | Mar 10, 2026 |
| Robert W. Baird | Analyst unavailable | $100 | $96.41 | +15.1% | Feb 18, 2026 |
| Barclays | Matt Miksic | $118 | $96.41 | +35.8% | Feb 18, 2026 |
| Needham | Analyst unavailable | $121 | $102.9 | +39.3% | Feb 9, 2026 |
| UBS | Analyst unavailable | $104 | $103.38 | +19.7% | Feb 4, 2026 |
| Wells Fargo | Larry Biegelsen | $114 | $101.78 | +31.2% | Jan 30, 2026 |
| Bernstein | Analyst unavailable | $112 | $98.69 | +28.9% | Jan 9, 2026 |
| Barclays | Matt Miksic | $116 | $99.77 | +33.5% | Jan 8, 2026 |
| Truist Financial | Richard Newitter | $107 | $99.14 | +23.2% | Dec 18, 2025 |
| Robert W. Baird | Analyst unavailable | $103 | $98.66 | +18.6% | Dec 16, 2025 |
| Barclays | Analyst unavailable | $111 | $100.34 | +27.8% | Nov 20, 2025 |
| Bernstein | Lee Hambright | $111 | $100.34 | +27.8% | Nov 19, 2025 |
| Leerink Partners | Mike Kratky | $120 | $100.8 | +38.1% | Nov 19, 2025 |
| Jefferies | Matthew Taylor | $110 | $100.8 | +26.6% | Nov 19, 2025 |
| Goldman Sachs | David Roman | $111 | $100.8 | +27.8% | Nov 19, 2025 |
| Bernstein | Lee Hambright | $98 | $91.16 | +12.8% | Oct 31, 2025 |
| Truist Financial | Analyst unavailable | $103 | $95.26 | +18.6% | Oct 15, 2025 |
| RBC Capital | Analyst unavailable | $111 | $95.72 | +27.8% | Oct 10, 2025 |
| Argus Research | David Toung | $115 | $92.18 | +32.4% | Aug 26, 2025 |
| Bernstein | Lee Hambright | $93 | $82.68 | +7.0% | Jan 8, 2025 |
| Robert W. Baird | David Rescott | $96 | $90.01 | +10.5% | Oct 15, 2024 |
| RBC Capital | Shagun Singh | $105 | $88.35 | +20.9% | Oct 10, 2024 |
| Evercore ISI | Vijay Kumar | $104 | $90.03 | +19.7% | Oct 1, 2024 |
| Citigroup | Joanne Wuensch | $92 | $90.03 | +5.9% | Oct 1, 2024 |
| Goldman Sachs | David Roman | $82 | $86.4 | -5.6% | Aug 21, 2024 |
| Oppenheimer | Steven Lichtman | $94 | $86.46 | +8.2% | Aug 21, 2024 |
| Piper Sandler | Matt O'Brien | $90 | $85.38 | +3.6% | Aug 21, 2024 |
| Mizuho Securities | Anthony Petrone | $98 | $86.38 | +12.8% | Aug 21, 2024 |
| Wells Fargo | Larry Biegelsen | $106 | $85.38 | +22.0% | Aug 21, 2024 |
| Stifel Nicolaus | Rick Wise | $87 | $85.38 | +0.1% | Aug 20, 2024 |
| Robert W. Baird | David Rescott | $87 | $81.91 | +0.1% | May 24, 2024 |
| RBC Capital | Shagun Singh | $92 | $81.38 | +5.9% | May 24, 2024 |
| Truist Financial | Richard Newitter | $88 | $81.38 | +1.3% | May 24, 2024 |
| Wells Fargo | Larry Biegelsen | $105 | $81.38 | +20.9% | May 24, 2024 |
| Stifel Nicolaus | Rick Wise | $100 | $81.38 | +15.1% | May 23, 2024 |
| Wells Fargo | Larry Biegelsen | $102 | $80.98 | +17.4% | Sep 13, 2023 |
| Robert W. Baird | David Rescott | $90 | $82.94 | +3.6% | Aug 10, 2023 |
| Wells Fargo | Larry Biegelsen | $100 | $87.29 | +15.1% | Jul 12, 2023 |
| RBC Capital | Analyst unavailable | $89 | $80.86 | +2.4% | Jan 9, 2023 |
| Wells Fargo | Analyst unavailable | $77 | $76.49 | -11.4% | Nov 30, 2022 |
| Barclays | Analyst unavailable | $85 | $79.12 | -2.2% | Nov 25, 2022 |
| Morgan Stanley | Cecilia Furlong | $88 | $78.53 | +1.3% | Nov 23, 2022 |
| Deutsche Bank | Pito Chickering | $80 | $78.53 | -7.9% | Nov 23, 2022 |
| RBC Capital | Analyst unavailable | $102 | $78.84 | +17.4% | Nov 23, 2022 |
| Oppenheimer | Analyst unavailable | $85 | $77.97 | -2.2% | Nov 23, 2022 |
| Citigroup | Analyst unavailable | $85 | $77.93 | -2.2% | Nov 23, 2022 |
| Deutsche Bank | Pito Chickering | $85 | $83.4 | -2.2% | Nov 16, 2022 |
| RBC Capital | Analyst unavailable | $110 | $86.04 | +26.6% | Sep 7, 2022 |
| Morgan Stanley | Analyst unavailable | $101 | $89.32 | +16.3% | Aug 24, 2022 |
| Wells Fargo | Larry Biegelsen | $96 | $90.22 | +10.5% | Aug 24, 2022 |
| Truist Financial | Analyst unavailable | $97 | $88.9 | +11.6% | Jul 20, 2022 |
| Stifel Nicolaus | Analyst unavailable | $105 | $88.94 | +20.9% | Jul 18, 2022 |
| Morgan Stanley | Analyst unavailable | $103 | $89.04 | +18.6% | Jul 15, 2022 |
| Morgan Stanley | Analyst unavailable | $114 | $95.84 | +31.2% | Jun 7, 2022 |
| Truist Financial | Analyst unavailable | $111 | $100.03 | +27.8% | May 31, 2022 |
| Raymond James | Analyst unavailable | $109 | $99.08 | +25.5% | May 31, 2022 |
| Cowen & Co. | Analyst unavailable | $117 | $97.37 | +34.7% | May 27, 2022 |
| RBC Capital | Analyst unavailable | $122 | $98.27 | +40.4% | May 27, 2022 |
| Deutsche Bank | Analyst unavailable | $121 | $98.25 | +39.3% | May 27, 2022 |
| Morgan Stanley | Analyst unavailable | $115 | $98.24 | +32.4% | May 27, 2022 |
| Citigroup | Analyst unavailable | $117 | $98.6 | +34.7% | May 27, 2022 |
| Cowen & Co. | Josh Jennings | $117 | $99.08 | +34.7% | May 27, 2022 |
| RBC Capital | Shagun Singh Chadha | $122 | $99.08 | +40.4% | May 27, 2022 |
| Cowen & Co. | Analyst unavailable | $125 | $104.12 | +43.9% | May 23, 2022 |
| Bank of America Securities | Travis Steed | $135 | $107.65 | +55.4% | Mar 3, 2022 |
| Needham | Michael Matson | $124 | $105.84 | +42.7% | Feb 26, 2022 |
| Raymond James | Jayson Bedford | $116 | $99.98 | +33.5% | Feb 18, 2022 |
| Piper Sandler | Matthew O'Brien | $105 | $102.54 | +20.9% | Feb 16, 2022 |
| Citigroup | Joanne Wuensch | $129 | $107.12 | +48.5% | Jan 19, 2022 |
| Piper Sandler | Matt O’Brien | $110 | $108.55 | +26.6% | Jan 16, 2022 |
| Morgan Stanley | Cecilia Furlong | $120 | $104.54 | +38.1% | Jan 7, 2022 |
| Truist Financial | David Rescott | $124 | $101.05 | +42.7% | Dec 21, 2021 |
| J.P. Morgan | Robbie Marcus | $105 | $99.4 | +20.9% | Dec 17, 2021 |
| Wells Fargo | Larry Biegelsen | $110 | $100.96 | +26.6% | Dec 16, 2021 |
| UBS | Matthew Taylor | $135 | $100.96 | +55.4% | Dec 16, 2021 |
| Guggenheim | Christopher Pasquale | $142 | $113.04 | +63.4% | Nov 24, 2021 |
| Jefferies | Anthony Petrone | $155 | $111.99 | +78.4% | Nov 23, 2021 |
| Argus Research | David Toung | $165 | $131.53 | +89.9% | Aug 27, 2021 |
| Cowen & Co. | Josh Jennings | $141 | $122 | +62.3% | Jun 10, 2021 |
Track every rating change on MDT the moment it posts. Free to start.
Start free